Patent details

Basic Information

Publication number:

EP2235535

PCT Application Number:

PCT/US/2008/013448

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088595087

PCT Publication Number:

WO/2009/075797

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

BIOMARKERS FOR PREDICTING THE SENSITIVITY OF CELLS TO IMMUNOMODULATORY COMPOUNDS DURING TREATMENT OF NON-HODGKIN'S LYMPHOMA

French Title of Invention:

BIOMARQUEURS POUR PRÉDIRE LA SENSIBILITÉ DE CELLULES À DES COMPOSÉS IMMUNORÉGULATEURS PENDANT UN TRAITEMENT DE LYMPHOME NON HODGKINIEN

German Title of Invention:

BIOMARKER ZUR VORHERSAGE DER EMPFINDLICHKEIT VON ZELLEN GEGENÜBER IMMUNMODULATORISCHEN VERBINDUNGEN WÄHREND DER BEHANDLUNG VON NON-HODGKIN-LYMPHOM

SPC Number:

Dates

Filing date:

05/12/2008

Grant date:

12/11/2014

EP Publication Date:

12/11/2014

PCT Publication Date:

18/06/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/10/2010

EP B1 Publication Date:

12/11/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/12/2014

Expiration date:

05/12/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/12/2008

 

 

Name:

CELGENE CORPORATION

Address:

86 Morris Avenue, Summit, NJ 07901, United States (US)

Inventor

1

Name:

ZHANG Ling-Hua

Address:

United States (US)

2

Name:

BARTLETT Justin, B.

Address:

United States (US)

3

Name:

SCHAFER Peter, H.

Address:

United States (US)

Priority

Priority Number:

5806 P

Priority Date:

07/12/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

G01N 33/574;

Filing date	Document type	Number of pages